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Helicobacter (H.) suis is a porcine gastric pathogen, which is also considered to be of 9 
zoonotic importance. No in vitro antimicrobial susceptibility data are available for this very 10 
fastidious micro-organism that only grows on a biphasic culture medium. Therefore, a 11 
combined agar and broth dilution method followed by a standardized H. suis specific 12 
quantitative real-time PCR (qPCR) assay was used to analyse the activity of 9 antimicrobial 13 
agents: ampicillin, ceftiofur, clarithromycin, enrofloxacin, gentamicin, lincomycin, 14 
metronidazole, tetracycline, and tylosine. After 48 hours microaerobic incubation, minimal 15 
inhibitory concentrations (MICs) were determined for 9 H. suis isolates by software-assisted 16 
calculation of bacterial growth. One, one and three isolates displayed acquired resistance to 17 
enrofloxacin, lincomycin and ceftiofur, respectively, as indicated by a bimodal distribution of 18 
the MICs. The MICs of ampicillin displayed a monomodal distribution, but with tailing 19 
toward the higher MIC values for 5 isolates, possibly indicating reduced susceptibility. For 20 
the other antimicrobial agents a monomodal distribution of MIC values was observed, 21 
indicating absence of acquired resistance, although in 7 isolates, MICs of metronidazole were 22 
equal or higher than the breakpoint proposed for H. pylori. The significance of the findings 23 
presented here for treatment of humans or animals infected with H. suis needs further 24 
investigation.  25 
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